PPARG and neoplasm: Yu et al. demonstrated that PPARγ-deficient (PPARγ+/−) mice were susceptible to diethylnithrosamine-induced liver carcinogenesis compared with wild-type mice (PPARγ+/+), suggesting that PPARγ functions as a tumor suppressor in hepatocarcinogenesis [12].